CN1813974A - Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati - Google Patents

Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati Download PDF

Info

Publication number
CN1813974A
CN1813974A CN 200510128413 CN200510128413A CN1813974A CN 1813974 A CN1813974 A CN 1813974A CN 200510128413 CN200510128413 CN 200510128413 CN 200510128413 A CN200510128413 A CN 200510128413A CN 1813974 A CN1813974 A CN 1813974A
Authority
CN
China
Prior art keywords
radix
parts
herba
folium
schefflerae arboricolae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510128413
Other languages
Chinese (zh)
Inventor
王浩贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200510128413 priority Critical patent/CN1813974A/en
Publication of CN1813974A publication Critical patent/CN1813974A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a Cisanjia Qufeng Tongluo Zhitong medicine for effectively curing the diseases of rheumatic arthralgia, rheumatic arthritis, arthralgia and myalgia, soft tissue contusion and traumatic injury, etc. with obvious therapeutic effect. It is made up by using 14 Chinese medicinal materials of trifoliate acanthopanax root, aconite main tuber, clerodendron serratum, chamaerhodos erecta, beaumontia grandiflora and others and adding white liquor through a certain preparation process.

Description

A kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product
Technical field:
The present invention relates to a kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product.
Background technology:
Traumatic injury, the Fengshi Guanjie disease is a kind of common disease, the people who from ancient times to the present suffers from this disease is a lot, is subjected to ailing the torment deeply, in the market the various traumatic injury of Xiao Shouing, Fengshi Guanjie disease medicine for external use is also a lot, but no matter be Western medicine or Chinese medicine, for this class Drug therapy traumatic injury, the slight illness of Fengshi Guanjie disease has played certain therapeutical effect really, but also there is not a kind of ideal treatment traumatic injury, the specific drug of Fengshi Guanjie disease.
Summary of the invention:
The inventor has a kind of treatment traumatic injury at above-mentioned weak point at pressing for of patient, the dispelling wind and removing obstruction in the collateral analgesic medicine for external use of Fengshi Guanjie disease; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, it can be to traumatic injury, and the Fengshi Guanjie disease is carried out treating both the principal and secondary aspects of a disease, reaches good therapeutic effect.
Purpose of the present invention just provides a kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product.
Choice of drug Radix Acanthopanacis Trifoliati of the present invention, Radix Aconiti, Herba Clerodendri Serrati, Herba Chamaerhodoris Erectae, Rhizoma Smilacis Bockii, Radix Beaumontiae Grandiflorae, Radix Crotonis Crassifolii, Herba Lysionoti Pauciflori, Folium Et Cacumen Murrayae, Radix Pileae Plataniflorae, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Rhizoma Rodgersiae, Radix Berchemiae Giraldianae, Radix seu Folium Cinnamomi angustifolii, ethanol (concentration is 35-75%) are formed; Wherein select Radix Acanthopanacis Trifoliati for use: have expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation; Treating rheumatic arthritis, traumatic injury.Select Radix Aconiti for use: have expelling wind and removing dampness, antalgic, dredge the meridian passage; Control anemofrigid-damp arthralgia, treating swelling and pain by traumatic injury is sprained and is swollen and ache.Select Herba Clerodendri Serrati for use: have expelling wind and removing dampness, dredge the meridian passage; Dispelling the wind and dampness pathogens pain, traumatic injury is sprained and is swollen and ache.Select Herba Chamaerhodoris Erectae for use: have wind-damp dispelling; Treating rheumatic arthritis.Select Rhizoma Smilacis Bockii for use: have expelling wind and activating blood circulation; Control traumatic injury, lumbago, skelalgia of rheumatism.Select Radix Beaumontiae Grandiflorae for use: have expelling wind and removing dampness, removing blood stasis and activating blood flow; Dispelling the wind and dampness pathogens waist leg joint pain, rheumatic arthritis, traumatic injury.Select Radix Crotonis Crassifolii for use: have regulating QI to relieve pain, expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral; Control traumatic injury, rheumatic arthritis.Select Herba Lysionoti Pauciflori for use: have removing obstruction in the collateral to relieve pain; Control stable damage, sprain pain.Select Folium Et Cacumen Murrayae for use: have promoting flow of QI and blood, expelling wind and removing dampness; Control treating swelling and pain by traumatic injury.Select Radix Pileae Plataniflorae for use: have activating collaterals to relieve pain, expelling wind and removing dampness; Control traumatic injury, rheumatic arthritis.Select Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) for use: have promoting blood circulation and stopping pain, expelling wind and removing dampness; Control traumatic injury, rheumatic arthritis, soft tissue contusion.Select Rhizoma Rodgersiae for use: have eliminating stasis to stop pain, detumescence is invigorated blood circulation, wind-damp dispelling; Treating rheumatic arthritis, traumatic injury.Select Radix Berchemiae Giraldianae for use: have wind-damp dispelling, promoting blood circulation to remove obstruction in the collateral; Control traumatic injury, rheumatic arthritis.Select Radix seu Folium Cinnamomi angustifolii for use: have relaxing muscles and tendons and activating QI and blood in the collateral, dispersing cold for relieving pain; Control traumatic injury, rheumatic arthralgia.Make the effect of each medicine produce collaborative effect above these drug regimens, to sprain the curative effect of disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion definite thereby can realize effectively treating rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, traumatic hemorrhage, muscles and bones, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following weight portion:
Radix Acanthopanacis Trifoliati 1-55 part, Radix Aconiti 1-35 part, Herba Clerodendri Serrati 1-35 part, Herba Chamaerhodoris Erectae 1-30 part, Rhizoma Smilacis Bockii 1-40 part, Radix Beaumontiae Grandiflorae 1-35 part, Radix Crotonis Crassifolii 1-35 part, Herba Lysionoti Pauciflori 1-40 part, Folium Et Cacumen Murrayae 1-30 part, Radix Pileae Plataniflorae 1-35 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-20 part, Rhizoma Rodgersiae 1-35 part, Radix Berchemiae Giraldianae 1-35 part and Radix seu Folium Cinnamomi angustifolii 1-30 part, ethanol (concentration is 35-75%) 42-1470 part.
Optimization formula of the present invention is:
20 parts of 38 parts of Radix Acanthopanacis Trifoliatis, 25 parts of Radix Aconitis, 25 parts of Herba Clerodendri Serratis, 20 parts of Herba Chamaerhodoris Erectaes, 28 parts of Rhizoma Smilacis Bockii, 22 parts of Radix Beaumontiae Grandiflorae, 20 parts of Radix Crotonis Crassifoliis, 25 parts of Herba Lysionoti Paucifloris, 20 parts of Folium Et Cacumen Murrayae, 25 parts of Radix Pileae Platanifloraes, 10 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 25 parts of Rhizoma Rodgersiae, 25 parts of Radix Berchemiae Giraldianae and Radix seu Folium Cinnamomi angustifolii, 984 parts of ethanol (concentration is 35-75%).
A kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, traumatic hemorrhage, muscles and bones sprain the disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares better efficacy with existing similar medicine for external use curative effect.A kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product of the present invention was once done a large amount of clinical trials in early stage, inferior to over one hundred example on the patient treatment case before this, comprise being used for the treatment of the disease that rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, traumatic hemorrhage, muscles and bones are sprained pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion, do not see untoward reaction during the treatment; Total effective rate is more than 85%, and therapeutic effect is very good.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, and affected part is wiped to generating heat for good every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product provided by the present invention is made up of the component of following weight portion; Radix Acanthopanacis Trifoliati 1-55 part, Radix Aconiti 1-35 part, Herba Clerodendri Serrati 1-35 part, Herba Chamaerhodoris Erectae 1-30 part, Rhizoma Smilacis Bockii 1-40 part, Radix Beaumontiae Grandiflorae 1-35 part, Radix Crotonis Crassifolii 1-35 part, Herba Lysionoti Pauciflori 1-40 part, Folium Et Cacumen Murrayae 1-30 part, Radix Pileae Plataniflorae 1-35 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-20 part, Rhizoma Rodgersiae 1-35 part, Radix Berchemiae Giraldianae 1-35 part and Radix seu Folium Cinnamomi angustifolii 1-30 part, ethanol (concentration is 35-75%) 42-1470 part.
Embodiment 2:
Optimization formula of the present invention is:
20 parts of 38 parts of Radix Acanthopanacis Trifoliatis, 25 parts of Radix Aconitis, 25 parts of Herba Clerodendri Serratis, 20 parts of Herba Chamaerhodoris Erectaes, 28 parts of Rhizoma Smilacis Bockii, 22 parts of Radix Beaumontiae Grandiflorae, 20 parts of Radix Crotonis Crassifoliis, 25 parts of Herba Lysionoti Paucifloris, 20 parts of Folium Et Cacumen Murrayae, 25 parts of Radix Pileae Platanifloraes, 10 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 25 parts of Rhizoma Rodgersiae, 25 parts of Radix Berchemiae Giraldianae and Radix seu Folium Cinnamomi angustifolii, 984 parts of ethanol (concentration is 35-75%).
Preparation method of the present invention is: at first with above-mentioned Radix Acanthopanacis Trifoliati, Radix Aconiti, Herba Clerodendri Serrati, Herba Chamaerhodoris Erectae, Rhizoma Smilacis Bockii, Radix Beaumontiae Grandiflorae, Radix Crotonis Crassifolii, Herba Lysionoti Pauciflori, Folium Et Cacumen Murrayae, Radix Pileae Plataniflorae, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Rhizoma Rodgersiae, Radix Berchemiae Giraldianae, Radix seu Folium Cinnamomi angustifolii, the single respectively granularity control of grinding into is as the grain of rice between the size, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 35-75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or soaked 15-20 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.

Claims (3)

1, a kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product is characterized in that: Radix Acanthopanacis Trifoliati, Radix Aconiti, Herba Clerodendri Serrati, Herba Chamaerhodoris Erectae, Rhizoma Smilacis Bockii, Radix Beaumontiae Grandiflorae, Radix Crotonis Crassifolii, Herba Lysionoti Pauciflori, Folium Et Cacumen Murrayae, Radix Pileae Plataniflorae, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Rhizoma Rodgersiae, Radix Berchemiae Giraldianae, Radix seu Folium Cinnamomi angustifolii, ethanol (concentration is 35-75%) are formed.
2, a kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product according to claim 1, it is characterized in that: the component by following weight portion is formed; Radix Acanthopanacis Trifoliati 1-55 part, Radix Aconiti 1-35 part, Herba Clerodendri Serrati 1-35 part, Herba Chamaerhodoris Erectae 1-30 part, Rhizoma Smilacis Bockii 1-40 part, Radix Beaumontiae Grandiflorae 1-35 part, Radix Crotonis Crassifolii 1-35 part, Herba Lysionoti Pauciflori 1-40 part, Folium Et Cacumen Murrayae 1-30 part, Radix Pileae Plataniflorae 1-35 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 1-20 part, Rhizoma Rodgersiae 1-35 part, Radix Berchemiae Giraldianae 1-35 part and Radix seu Folium Cinnamomi angustifolii 1-30 part.
3, a kind of Radix Acanthopanacis Trifoliati dispelling wind and removing obstruction in the collateral analgesic drug product according to claim 1, it is characterized in that: the component by following weight portion is formed; 20 parts of 38 parts of Radix Acanthopanacis Trifoliatis, 25 parts of Radix Aconitis, 25 parts of Herba Clerodendri Serratis, 20 parts of Herba Chamaerhodoris Erectaes, 28 parts of Rhizoma Smilacis Bockii, 22 parts of Radix Beaumontiae Grandiflorae, 20 parts of Radix Crotonis Crassifoliis, 25 parts of Herba Lysionoti Paucifloris, 20 parts of Folium Et Cacumen Murrayae, 25 parts of Radix Pileae Platanifloraes, 10 parts of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)s, 25 parts of Rhizoma Rodgersiae, 25 parts of Radix Berchemiae Giraldianae and Radix seu Folium Cinnamomi angustifolii.
CN 200510128413 2005-11-23 2005-11-23 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati Pending CN1813974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510128413 CN1813974A (en) 2005-11-23 2005-11-23 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510128413 CN1813974A (en) 2005-11-23 2005-11-23 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati

Publications (1)

Publication Number Publication Date
CN1813974A true CN1813974A (en) 2006-08-09

Family

ID=36906406

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510128413 Pending CN1813974A (en) 2005-11-23 2005-11-23 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati

Country Status (1)

Country Link
CN (1) CN1813974A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566077A (en) * 2013-10-31 2014-02-12 高东芹 Medicament for treating hysteromyoma

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566077A (en) * 2013-10-31 2014-02-12 高东芹 Medicament for treating hysteromyoma
CN103566077B (en) * 2013-10-31 2016-02-17 张志平 A kind of medicament for the treatment of hysteromyoma

Similar Documents

Publication Publication Date Title
CN100551418C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1813974A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati
CN100551415C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1739624A (en) Externally applied medicine of aizoon stonecrop root
CN1813944A (en) External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals
CN1814134A (en) Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls
CN100534512C (en) Externally applied medicine of Yunan camptandra root
CN1739693A (en) Externally applied medicine of dunn tongoloa root
CN1813898A (en) External-use medicine of hayberry bark for traumatic injury and activating collaterals
CN1813997A (en) Wind-repellent pain-relieving medicine of Radix et caulis chimonanthi Proecocis
CN1814142A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Callicarpae Longissimae
CN1814104A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix seu Folium Lobeliae Seguinit
CN1814203A (en) Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls
CN1813963A (en) External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows
CN1742856A (en) Radix aconitic kusnezoffii external-use medicine
CN1739646A (en) Externally applied medicine of thickleaf croton root
CN1739636A (en) Externally applied medicine of Chinese tinospora stem
CN1739708A (en) Externally applied medicine of cannalike dona rhizome
CN1742839A (en) Nutritious health-care oral liquor for woman and preparing process
CN1813907A (en) External-use medicine of cordateleaf ainsliaea root for traumatic injury and activating collaterals
CN1814088A (en) Wind-repellent collateral-activating pain-relieving medicine of Radix Rhodiolae
CN1739634A (en) Externally applied medicine of safflower
CN1739644A (en) Externally applied medicine of fortune silene herb
CN1813990A (en) Cortex Berheridis Radicis external-use medicine
CN1813854A (en) External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication